134865-74-0
基本信息
4-P-PDOT
4-PHENYL-2-PROPIONAMIDOTETRALIN
N-(4-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanamide
N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propionamide
Propanamide, N-(1,2,3,4-tetrahydro-4-phenyl-2-naphthalenyl)-
4-P-PDOT
4PPDOT
4P-PDOT
AH-024
4-PHENYL-2- PROPIONAMIDOTETRALIN.
物理化学性质
| 熔点 | 166 °C |
| 沸点 | 480.1±45.0 °C(Predicted) |
| 密度 | 1.11±0.1 g/cm3(Predicted) |
| 储存条件 | Store at RT |
| 溶解度 | Soluble in DMSO > 10 mM |
| 酸度系数(pKa) | 15.87±0.40(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色至米色 |
安全数据
| 危险性符号(GHS) |  GHS07 |
| 警示词 | 警告 |
| 危险性描述 | H302 |
| 防范说明 | P264-P270-P301+P312-P330-P501 |
| RTECS号 | TX1498350 |
| 海关编码 | 2924.29.7790 |
4-P-PDOT价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/02/08 | HY-100609 | 4-P-PDOT 4-P-PDOT | 134865-74-0 | 1mg | 394元 |
| 2025/02/08 | HY-100609 | 4-P-PDOT 4-P-PDOT | 134865-74-0 | 5mg | 900元 |
| 2025/02/08 | HY-100609 | 4-P-PDOT 4-P-PDOT | 134865-74-0 | 10mM * 1mLin DMSO | 1211元 |
常见问题列表
MT2 receptor
In CHO-mt1 cells the amidotetraline 4-P-PDOT (10 mM) has no effect on forskolin-stimulated cyclic AMP levels, either alone, or in the presence of Melatonin. In contrast, in CHO-MT2 cells, 4-P-PDOT is an agonist, producing a concentration-dependent inhibition of forskolin stimulated cyclic AMP, with a pEC 50 value of 8.72 and intrinsic activity of 0.86.
Cell Viability Assay
| Cell Line: | HT-29 and HeLa cells. |
| Concentration: | 30 min. |
| Incubation Time: | 50 µM. |
| Result: | Produced a negligible effect on cell viability induced by melatonin. |
4-P-PDOT (0.5-1.0 mg/kg; intravenous injection; klotho mutant mice) treatment significantly reverses antioxidant effects mediated by Melatonin. And significantly reverses the changes in the levels of these GSH-related parameters. 4-P-PDOT treatment significantly reverses the memory function of Melatonin-treated klotho mutant mice. 4-P-PDOT also counteracts Melatonin-mediated attenuation in response to the decreases in phospho-ERK expression, Nrf2 nuclear translocation, Nrf2 DNA-binding activity, and GCL mRNA expression in the hippocampi of klotho mutant mice.
| Animal Model: | Klotho mutant mice treatment with Melatonin |
| Dosage: | 0.5 mg/kg or 1.0 mg/kg |
| Administration: | Intravenous injection |
| Result: | Significantly reversed antioxidant effects mediated by Melatonin. Significantly reversed the changes in the levels of these GSH-related parameters. Significantly reversed the memory function of Melatonin-treated klotho mutant mice. |